Tumor necrosis factor-α (TNF-α) stimulates osteoblast production of interleukin-6 (IL-6), an inflammatory cytokine implicated in osteoclastic bone resorption. Therefore, we tested the hypothesis that TNF-α-induced IL-6 production in MG-63 osteosarcoma cells occurs via the p38 mitogen-activated protein kinase (MAPK) pathway. TNF-α activated p38 MAPK and stimulated IL-6 secretion by MG-63 cells, and inhibitor abrogated TNF-α-dependent IL-6 secretion. Transfection of IL-6 full-length and 5'-deletion gene promoter reporter constructs indicated that p38 MAPK activation by TNF-α enhanced IL-6 gene expression, and that the p38 MAPK-responsive region resided in the proximal 260-bp segment. Transfection of NFκB and C/EBPβ-sensitive reporter promoter constructs demonstrated that NFκB activity was enhanced and that constitutive C/EBPβ was inhibited by TNF-α, with both effects being p38 MAPK-dependent. In conclusion, although p38 MAPK activation by TNF-α stimulates IL-6 secretion by MG-63 cells, it has opposing effects on c/EBPβ and NFκB activity.
AkiraS., KishimotoT. (1992). IL-6 and NF-IL6 in acute phase response and viral infection.Immunol Rev127: 25–50.
2.
AlonsoG., AmbrosinoC., JonesM., NebredaA. (2000). Differential activation of p38 MAP kinase isoforms depending upon signal strength.J Biol Chem275: 40641–40648.
3.
BadgerA.M., GriswoldD.E., KapadiaR., BlakeS., SwiftB.A., HoffmanS.J.. (2000). Disease-modifying activity of SB242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis.Arthritis Rheum43: 175–183.
4.
BaldassareJ.J., BiY., BelloneC.J. (1999). The role of p38 mitogen-activated protein kinase in IL-1 beta transcription.J Immunol162: 5367–5373.
5.
BlanqueR., CottereauxC., GardnerC.R. (1997). Effects of SK&F 86002 on cytokine-stimulated IL-6 production in cultured neonatal mouse calvaria and SaOS2 osteoblastic cells: the role of prostaglandins and other mechanisms of action.Drugs Exp Clin Res23: 63–70.
6.
CaivanoM., CohenP. (2000). Role of mitogen-activated protein kinase cascades in mediating lipopolysaccharide-stimulated induction of cyclooxygenase-1 and IL-1 beta in RAW264 macrophages.J Immunol164: 3018–3025.
7.
ChaeH.J., ChaeS.W., ChinH.Y., BangB.G., ChoS.B., HanS.K.. (2001). The p38 mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumor necrosis factor in osteoblasts.Bone28: 45–53.
8.
ChambersT.J., FullerK. (1985). Bone cells predispose bone surfaces to resorption by exposure of mineral to osteoclastic surfaces.J Cell Sci76: 155–165.
9.
ChaudharyL.R., AvioliL.V. (1997). Activation of extracellular signal-related kinases 1 and 2 by FGF-2 and PDGF-BB in normal human osteoblastic and bone marrow stromal cells: differences in mobility and in-gel renaturation of ERK1 in human, rat, and mouse osteoblastic cells.Biochem Biophys Res Commun238: 134–139.
10.
ChaudharyL.R., AvioliL.V. (1998). Identification and activation of mitogen activated protein (MAP) kinase in normal human osteoblastic and bone marrow stromal cells: attenuation of MAP kinase activation by camp, parathyroid hormone and forskolin.Mol Cell Biochem178: 59–68.
11.
EickelbergO., PanskyA., MussmannR., BihlM., TammM., HildebrandP.. (1999). Transforming growth factor-beta 1 induces interleukin-6 expression via activating protein-1 consisting of junD homodimers in primary human lung fibroblasts.J Biol Chem274: 12933–12938.
12.
FranchimontN., DurantD., RydzielS., CanalisE. (1999). Platelet-derived growth factor induces interleukin-6 transcription in osteoblasts through the activator protein-1 complex and activating transcription factor-2.J Biol Chem274: 6783–6789.
13.
FullerK., GallagherA., ChambersT.J. (1991). Osteoclast resorption-stimulating activity is associated with osteoblast cells and/or the extracellular matrix.Biochem Biophys Res Commun181: 67–73.
14.
GalienR., GarciaT. (1997). Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site.Nucleic Acids Res25: 2424–2429.
15.
HuH.M., TianQ., BaerM., SpoonerC.J., WilliamsS.C., JohnsonP.F.. (2000). The C/EBP bZIP domain can mediate lipopolysaccharide induction of the pro-inflammatory cytokines interleukin-6 and monocyte chemoattractant protein-1.J Biol Chem275: 16373–16381.
16.
IshimiY., MiyauraC., JinC.H., AkatsuT., AbeE., NakamuraY.. (1990). IL-6 is produced by osteoblasts and induces bone resorption.J Immunol145: 3297–3303.
17.
KozawaO., TokudaH., MatsunoU., UematsuT. (1999). Involvement of p38 mitogen-activated protein kinase in basic fibroblast growth factor-induced interleukin-6 synthesis in osteoblasts.J Cell Biochem74: 479–485.
18.
KumarS., VottaB.J., RiemanD.J., BadgerA.M., GowenM., LeeJ.C. (2001). IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase.J Cell Physiol187: 294–303.
ManolagasS.C. (1995). Role of cytokines in bone resorption.Bone17: 63S–67S.
21.
MerolaM., BlanchardB., ToveyM.G. (1996). The kappa B enhancer of the human interleukin-6 promoter is necessary and sufficient to confer an IL-lbeta and TNF-alpha response in transfected human cell lines: requirement for members of the C/EBP family for activity.J Interferon Cyt Res16: 783–798.
22.
MiwaM., KozawaO., TokudaH., UematsuT. (1999). Mitogen-activated protein kinases are involved in interleukin-induced IL-6 synthesis in osteoblasts: modulation not of p38 MAP kinase, but of p42/p44 MAP kinase by IL-l-activated protein kinase C.Endocrinology140: 5120–5125.
23.
MiyazawaK., MoriA., MiyataH., AkahaneM., AjisawaY., OkudairaH. (1998). Regulation of interleukin-1β-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen activated protein kinase.J Biol Chem273: 24832–24838.
24.
PahanK., LiuX., McKinneyM.J., WoodC., SheikhF.G., RaymondJ.R. (2000). Expression of dominant-negative mutant of p21(ras) inhibits induction of nitric oxide synthase and activation of nuclear factor-kappaB in primary astrocytes.J Neurochem74: 2288–2295.
25.
RayA., Sassone-CorsiP., SehgalP.B. (1989). A multiple cytokine- and second messenger-responsive element in the enhancer of the human interleukin-6 gene: similarities with c-fos regulation.Mol Cell Biol9: 5537–5547.
26.
RozenN., Ish-ShalomS., RachmielA., SteinH., LewinsonD. (2000). Interleukin-6 modulates trabecular and endochondral bone turnover in the nude mouse by stimulating osteoclast differentiation.Bone26: 469–474.
27.
SchaefferH.J., WeberM.J. (1999). Mitogen-activated protein kinases: specific messages from ubiquitous messengers.Mol Cell Biol19: 2435–2444.
28.
SiddhantiS.R., HartleJ.E., QuarlesL.D. (1995). Forskolin inhibits protein kinase C-induced mitogen activated protein kinase activity in MC3T3-E1 osteoblasts.Endocrinology136: 4834–4841.
29.
ThomsonB.M., MundyG.R., ChambersT.J. (1987). Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption.J Immunol138: 775–779.
30.
ThomsonS., MahadevanL.C., ClaytonA.C. (1999). MAP kinase-mediated signalling to nucleosomes and immediate-early gene induction.Sem Cell Dev Biol10: 205–214.
31.
Vanden BergheW., PlaisanceS., BooneE., De BosscherK., SchmitzM.L., FiersW.. (1998). p38 and extracellular signal-related kinase mitogen activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor.J Biol Chem273: 3285–3290.
32.
Vanden BergheW., VermuelenL., De WildeG., De BosscherK., BooneE., HaegemanG. (2000). Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6.Biochem Pharmacol60: 1185–1195.
33.
VerheijenM.H., DefizeL.H. (1995). Parathyroid hormone inhibits mitogen-activated protein kinase activation in osteosarcoma cells via a protein kinase A-dependent pathway.Endocrinology136: 3331–3337.
